Obesity and the Obesity Paradox in Heart Failure

Progress in Cardiovascular Diseases

Volumn 61, Issue 2, 2018, Pages 151-156

  Horwich, Tamara B ^a   Fonarow, Gregg C ^a   Clark, Adrienne L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Body mass index; Heart failure; Obesity paradox; Waist circumference

Indexed keywords

BARIATRIC SURGERY; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; BODY WEIGHT LOSS; CACHEXIA; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; DIET THERAPY; DISEASE SEVERITY; EXERCISE; HEART FAILURE; HUMAN; IMPEDANCE; OBESITY; PROGNOSIS; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; SEX DIFFERENCE; SKINFOLD THICKNESS; SURVIVAL RATE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ETHNOLOGY; FEMALE; HEALTH STATUS; MALE; METABOLICALLY BENIGN OBESITY; MORTALITY; PATHOPHYSIOLOGY; PREVALENCE; PROTECTION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX FACTOR;

CACHEXIA; CARDIORESPIRATORY FITNESS; FEMALE; HEALTH STATUS; HEART FAILURE; HUMANS; MALE; OBESITY; OBESITY, METABOLICALLY BENIGN; PREVALENCE; PROGNOSIS; PROTECTIVE FACTORS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; WEIGHT LOSS;

EID: 85049321532     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2018.05.005     Document Type: Review

References (74)

1. Fryar, C.D., Carrol, M.D., Ogden, C.L., Prevalence of overweight, obesity, and extreme obesity among adults: United States, trends 1960–1962 through 2015–2016. 2016, NCHS Health E-Stat.
2. Bozkurt, B., Aguilar, D., Deswal, A., et al. Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association. Circulation 134 (2016), e535–e578.
3. Lewis, G.A., Schelbert, E.B., Williams, S.G., et al. Biological phenotypes of heart failure with preserved ejection fraction. J Am Coll Cardiol 70 (2017), 2186–2200.
4. Ather, S., Chan, W., Bozkurt, B., et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol 59 (2012), 998–1005.
5. Dunlay, S.M., Roger, V.L., Redfield, M.M., Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol, 14, 2017, 591.
6. Kenchaiah, S., Evans, J., Levy, D., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002), 305–313.
7. Kenchaiah, S., Sesso, H.D., Gaziano, J.M., Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation 119 (2009), 44–52.
8. Hu, G., Jousilahti, P., Antikainen, R., Katzmarzyk, P.T., Tuomilehto, J., Joint effects of physical activity, body mass index, waist circumference, and waist-to-hip ratio on the risk of heart failure. Circulation 121 (2010), 237–244.
9. Levitan, E., Yang, A., Wolk, A., Mittleman, M., Adiposity and incidence of heart failure hospitalization and mortality: a population-based prospective study. Circ Heart Fail 2 (2009), 202–208.
10. Neeland, I.J., Gupta, S., Ayers, C.R., et al. Relation of regional fat distribution to left ventricular structure and function: Neeland et al: fat distribution and cardiac morphology. Circ Cardiovasc Imaging 6 (2013), 800–807.
11. Lavie, C.J., Sharma, A., Alpert, M.A., et al. Update on obesity and obesity paradox in heart failure. Prog Cardiovasc Dis 58 (2016), 393–400.
12. Horwich, T., Fonarow, G., Hamilton, M., MacLellan, W., Woo, M., Tillisch, J., The relationship between obesity and mortality in patients with heart failure. J Am Coll Cardiol 38 (2001), 789–795.
13. Kenchaiah, S., Pocock, S.J., Wang, D., et al. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116 (2007), 627–636.
14. Fonarow, G., Srikanthan, P., Costanzo, M., Cintron, G., Lopatin, M., Investigators ASACa, An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 153 (2007), 74–81.
15. Sharma, A., Lavie, C.J., Borer, J.S., et al. Meta-analysis of the relation of body mass index to all-cause and cardiovascular mortality and hospitalization in patients with chronic heart failure. Am J Cardiol 115 (2015), 1428–1434.
16. Volgyi, E., Tylavsky, F.A., Lyytikainen, A., Suominen, H., Alen, M., Cheng, S., Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age. Obesity (Silver Spring) 16 (2008), 700–705.
17. Oreopoulos, A., Kalantar-Zadeh, K., McAlister, F., et al. Comparison of direct body composition assessment methods in patients with chronic heart failure. J Card Fail 16 (2010), 867–872.
18. Cornier, M.A., Despres, J.P., Davis, N., et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 124 (2011), 1996–2019.
19. Bigaard, J., Frederiksen, K., Tjonneland, A., et al. Waist circumference and body composition in relation to all-cause mortality in middle-aged men and women. Int J Obes 29 (2005), 778–784.
20. Janssen, I., Katzmarzyk, P.T., Ross, R., Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79 (2004), 379–384.
21. Clark, A.L., Fonarow, G.C., Horwich, T.B., Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail 17 (2011), 374–380.
22. Clark, A.L., Chyu, J., Horwich, T.B., The obesity paradox in men versus women with systolic heart failure. Am J Cardiol 110 (2012), 77–82.
23. Tsujimoto, T., Kajio, H., Abdominal Obesity, Is, Associated with an increased risk of all-cause mortality in patients with HFpEF. J Am Coll Cardiol 70 (2017), 2739–2749.
24. Lavie, C.J., Milani, R.V., Ventura, H.O., Adipose composition and heart failure prognosis: paradox or not?*. J Am Coll Cardiol 70 (2017), 2750–2751.
25. Lavie, C.J., Osman, A.F., Milani, R.V., Mehra, M.R., Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003), 891–894.
26. Paterna, S., Di Pasquale, P., Parrinello, G., et al. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study. J Am Coll Cardiol 45 (2005), 1997–2003.
27. Futter, J.E., Cleland, J.G., Clark, A.L., Body mass indices and outcome in patients with chronic heart failure. Eur J Heart Fail 13 (2011), 207–213.
28. Buch, E., Bradfield, J., Larson, T., Horwich, T., Effect of bioimpedance body composition analysis on function of implanted cardiac devices. Pacing Clin Electrophysiol 35 (2012), 681–684.
29. Iacobellis, G., Willens, H.J., Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22 (2009), 1311–1319 [quiz 1417-1318].
30. Iozzo, P., Myocardial, perivascular, and epicardial fat. Diabetes Care 34:Suppl. 2 (2011), S371–S379.
31. Mahabadi, A.A., Massaro, J.M., Rosito, G.A., et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 30 (2009), 850–856.
32. McAuley, P.A., Hsu, F.C., Loman, K.K., et al. Liver attenuation, pericardial adipose tissue, obesity, and insulin resistance: the Multi-Ethnic Study of Atherosclerosis (MESA). Obesity (Silver Spring) 19 (2011), 1855–1860.
33. Khawaja, T., Greer, C., Chokshi, A., et al. Epicardial fat volume in patients with left ventricular systolic dysfunction. Am J Cardiol 108 (2011), 397–401.
34. Doesch, C., Suselbeck, T., Leweling, H., et al. Bioimpedance analysis parameters and epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure. Obesity (Silver Spring) 18 (2010), 2326–2332.
35. Wu, C.-K., Tsai, H.-Y., M-YM, Su, et al. Pericardial fat is associated with ventricular tachyarrhythmia and mortality in patients with systolic heart failure. Atherosclerosis 241 (2015), 607–614.
36. Anker, S., Ponikowski, P., Varney, S., et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 349 (1997), 1050–1053.
37. Zamora, E., Díez-López, C., Lupón, J., et al. Weight loss in obese patients with heart failure. J Am Heart Assoc, 5, 2016.
38. Melenovsky, V., Kotrc, M., Borlaug, B.A., et al. Relationships between right ventricular function, body composition and prognosis in advanced heart failure. J Am Coll Cardiol 62 (2013), 1660–1670.
39. Nagarajan, V., Cauthen, C.A., Starling, R.C., Tang, W.H., Prognosis of morbid obesity patients with advanced heart failure. Congest Heart Fail 19 (2013), 160–164.
40. Lin, G.-M., Li, Y.-H., Yin, W.-H., et al. The obesity-mortality paradox in patients with heart failure in Taiwan and a collaborative meta-analysis for East Asian patients. Am J Cardiol 118 (2016), 1011–1018.
41. Butler, J., Howser, R., Portner, P.M., Pierson, R.N. III, Body mass index and outcomes after left ventricular assist device placement. Ann Thorac Surg 79 (2005), 66–73.
42. Hall, J.A., French, T.K., Rasmusson, K.D., et al. The paradox of obesity in patients with heart failure. J Am Acad Nurse Pract 17 (2005), 542–546.
43. Powell-Wiley, T.M., Ngwa, J., Kebede, S., et al. Impact of body mass index on heart failure by race/ethnicity from the get with the guidelines–heart failure (GWTG–HF) registry. JACC Heart Fail 6 (2018), 233–242.
44. Chase, P., Arena, R., Myers, J., et al. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am J Cardiol 101 (2008), 348–352.
45. Mancini, D.M., Eisen, H., Kussmaul, W., Mull, R., Edmunds, L.H. Jr., Wilson, J.R., Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991), 778–786.
46. Lavie, C.J., De Schutter, A., Parto, P., et al. Obesity and prevalence of cardiovascular diseases and prognosis—the obesity paradox updated. Prog Cardiovasc Dis 58 (2016), 537–547.
47. Lavie, C.J., Alpert, M.A., Arena, R., Mehra, M.R., Milani, R.V., Ventura, H.O., Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure. JACC Heart Fail 1 (2013), 93–102.
48. Clark, A.L., Fonarow, G.C., Horwich, T.B., Impact of cardiorespiratory fitness on the obesity paradox in patients with systolic heart failure. Am J Cardiol 115 (2015), 209–213.
49. McAuley, P.A., Keteyian, S.J., Brawner, C.A., et al. Exercise Capacity and the Obesity Paradox in Heart Failure: The FIT (Henry Ford Exercise Testing) Project. Mayo Clinic Proceedings. 2018.
50. Oktay, A.A., Lavie, C.J., Kokkinos, P.F., Parto, P., Pandey, A., Ventura, H.O., The interaction of cardiorespiratory fitness with obesity and the obesity paradox in cardiovascular disease. Prog Cardiovasc Dis 60 (2017), 30–44.
51. Davos, C.H., Doehner, W., Rauchhaus, M., et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 9 (2003), 29–35.
52. Anker, S.D., Negassa, A., Coats, A.J., et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 361 (2003), 1077–1083.
53. Mehra, M.R., Uber, P.A., Park, M.H., et al. Obesity and suppressed B-type natriuretic peptide levels in heart failure. J Am Coll Cardiol 43 (2004), 1590–1595.
54. Lavie, C.J., Milani, R.V., Ventura, H.O., Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 53 (2009), 1925–1932.
55. Niebauer, J., Volk, H.-D., Kemp, M., et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353 (1999), 1838–1842.
56. Kalantar-Zadeh, K., Block, G., Horwich, T., Fonarow, G.C., Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004), 1439–1444.
57. Mohamed-Ali, V., Goodrick, S., Bulmer, K., Holly, J.M., Yudkin, J.S., Coppack, S.W., Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Phys 277 (1999), E971–E975.
58. Packer, M., Leptin-aldosterone-neprilysin axis. Identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity. 137, 2018, 1614–1631.
59. Jackson, A., Stanforth, P., Gagnon, J., et al. The effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study. Int J Obes Relat Metab Disord 26 (2002), 789–796.
60. Romero-Corral, A., Somers, V., Sierra-Johnson, J., et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32 (2008), 959–966.
61. Romero-Corral, A., Somers, V., Sierra-Johnson, J., et al. Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J 28 (2007), 2087–2093.
62. Despres, J.P., Moorjani, S., Lupien, P.J., Tremblay, A., Nadeau, A., Bouchard, C., Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 10 (1990), 497–511.
63. Snijder, M., van Dam, R., Visser, M., Seidell, J., What aspects of body fat are particularly hazardous and how do we measure them?. Int J Epidemiol 35 (2006), 83–92.
64. Fadini, G.P., Bonora, B.M., Marcuzzo, G., et al. Circulating stem cells associate with adiposity and future metabolic deterioration in healthy subjects. J Clin Endocrinol Metab 100 (2015), 4570–4578.
65. Rider, O.J., Francis, J.M., Ali, M.K., et al. Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. J Am Coll Cardiol 54 (2009), 718–726.
66. Poirier, P., Giles, T.D., Bray, G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 26 (2006), 968–976.
67. McMurray, J.J., Adamopoulos, S., Anker, S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14 (2012), 803–869.
68. Yancy, C.W., Jessup, M., Bozkurt, B., et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. J Am Coll Cardiol, 2013, 2013.
69. Evangelista, L.S., Heber, D., Li, Z., Bowerman, S., Hamilton, M.A., Fonarow, G.C., Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J Cardiovasc Nurs 24 (2009), 207–215.
70. Pritchett, A.M., Deswal, A., Aguilar, D., et al. Lifestyle modification with diet and exercise in obese patients with heart failure - a pilot study. J Obes Weight Loss Ther 2 (2012), 1–8.
71. Horwich, T.B., Broderick, S., Chen, L., et al. Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure. Am J Cardiol 108 (2011), 1754–1759.
72. Flynn, K.E., Pina, I.L., Whellan, D.J., et al. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301 (2009), 1451–1459.
73. Ramani, G.V., McCloskey, C., Ramanathan, R.C., Mathier, M.A., Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure. Clin Cardiol 31 (2008), 516–520.
74. McCloskey, C.A., Ramani, G.V., Mathier, M.A., et al. Bariatric surgery improves cardiac function in morbidly obese patients with severe cardiomyopathy. Surg Obes Relat Dis 3 (2007), 503–507.